Identification of Medicinal Products

• The IDMP Working Group objectives: 

  • Ensure the awareness and understanding of the standards of the IDMP standards more globally by pharmaceutical regulators 

     

  • Clarify how and why these standards can add value to regulator business processes to improve the quality and effectiveness of shared regulatory functions, 

     

  • Share strategies and experiences for their successful and consistent implementation.

     

• Mandate document endorsed November 2016

   

Key Deliverables:

• Outreach and communication on IDMP

   

• Publish Frequently Asked Questions (Version 6)

   

• Publication of documents in relation to the activities identified in the Scope of the WG and sharing of the public documentation produced by the early adopters for their regional/national implementation.

The working group has an on-going project, preparing the FAQ Document Version 7 which will be updated and is considered a living document.